URI:
   DIR Return Create A Forum - Home
       ---------------------------------------------------------
       nCoV_info
  HTML https://ncovinfo.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: nCoV - discussion
       *****************************************************
       #Post#: 22--------------------------------------------------
       WHO: Statement on the second meeting of the International Health
        Regulations (2005) Emergency Commit
       By: Acutedevelopers Date: January 31, 2020, 2:20 am
       ---------------------------------------------------------
       Source:
  HTML https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov
       Statement on the second meeting of the International Health
       Regulations (2005) Emergency Committee regarding the outbreak of
       novel coronavirus (2019-nCoV)
       30 January 2020 Statement
       Geneva, Switzerland
       The second meeting of the Emergency Committee convened by the
       WHO Director-General under the International Health Regulations
       (IHR) (2005) regarding the outbreak of novel coronavirus 2019 in
       the People’s Republic of China, with exportations to other
       countries, took place on Thursday, 30 January 2020, from 13:30
       to 18:35 Geneva time (CEST). The Committee’s role is to give
       advice to the Director-General, who makes the final decision on
       the determination of a Public Health Emergency of International
       Concern (PHEIC). The Committee also provides public health
       advice or suggests formal Temporary Recommendations as
       appropriate. Proceedings of the meeting
       Members and advisors of the Emergency Committee
  HTML https://www.who.int/ihr/procedures/novel-coronavirus-2019/ec-22012020-members/en/<br
       />were convened by teleconference
       The Director-General welcomed the Committee and thanked them for
       their support. He turned the meeting over to the Chair,
       Professor Didier Houssin.
       Professor Houssin also welcomed the Committee and gave the floor
       to the Secretariat.
       A representative of the department of compliance, risk
       management, and ethics briefed the Committee members on their
       roles and responsibilities.
       Committee members were reminded of their duty of confidentiality
       and their responsibility to disclose personal, financial, or
       professional connections that might be seen to constitute a
       conflict of interest. Each member who was present was surveyed
       and no conflicts of interest were judged to be relevant to the
       meeting. There were no changes since the previous meeting.
       The Chair then reviewed the agenda for the meeting and
       introduced the presenters.
       Representatives of the Ministry of Health of the People’s
       Republic of China reported on the current situation and the
       public health measures being taken. There are now 7711 confirmed
       and 12167 suspected cases throughout the country. Of the
       confirmed cases, 1370 are severe and 170 people have died. 124
       people have recovered and been discharged from hospital.
       The WHO Secretariat provided an overview of the situation in
       other countries. There are now 83 cases in 18 countries. Of
       these, only 7 had no history of travel in China. There has been
       human-to-human transmission in 3 countries outside China. One of
       these cases is severe and there have been no deaths.
       At its first meeting, the Committee expressed divergent views on
       whether this event constitutes a PHEIC or not. At that time, the
       advice was that the event did not constitute a PHEIC, but
       theCommittee members agreed on the urgency of the situation and
       suggested that the Committee should continue its meeting on the
       next day, when it reached the same conclusion.
       This second meeting takes place in view of significant increases
       in numbers of cases and additional countries reporting confirmed
       cases.
       Conclusions and advice
       The Committee welcomed the leadership and political commitment
       of the very highest levels of Chinese government, their
       commitment to transparency, and the efforts made to investigate
       and contain the current outbreak. China quickly identified the
       virus and shared its sequence, so that other countries could
       diagnose it quickly and protect themselves, which has resulted
       in the rapid development of diagnostic tools.
       The very strong measures the country has taken include daily
       contact with WHO and comprehensive multi-sectoral approaches to
       prevent further spread. It has also taken public health measures
       in other cities and provinces; is conducting studies on the
       severity and transmissibility of the virus, and sharing data and
       biological material. The country has also agreed to work with
       other countries who need their support. The measures China has
       taken are good not only for that country but also for the rest
       of the world.
       The Committee acknowledged the leading role of WHO and its
       partners.
       The Committee also acknowledged that there are still many
       unknowns, cases have now been reported in five WHO regions in
       one month, and human-to-human transmission has occurred outside
       Wuhan and outside China.
       The Committee believes that it is still possible to interrupt
       virus spread, provided that countries put in place strong
       measures to detect disease early, isolate and treat cases, trace
       contacts, and promote social distancing measures commensurate
       with the risk. It is important to note that as the situation
       continues to evolve, so will the strategic goals and measures to
       prevent and reduce spread of the infection. The Committee agreed
       that the outbreak now meets the criteria for a Public Health
       Emergency of International Concern and proposed the following
       advice to be issued as Temporary Recommendations.
       The Committee emphasized that the declaration of a PHEIC should
       be seen in the spirit of support and appreciation for China, its
       people, and the actions China has taken on the frontlines of
       this outbreak, with transparency, and, it is to be hoped, with
       success. In line with the need for global solidarity, the
       Committee felt that a global coordinated effort is needed to
       enhance preparedness in other regions of the world that may need
       additional support for that.
       Advice to WHO
       The Committee welcomed a forthcoming WHO multidisciplinary
       technical mission to China, including national and local
       experts. The mission should review and support efforts to
       investigate the animal source of the outbreak, the clinical
       spectrum of the disease and its severity, the extent of
       human-to-human transmission in the community and in healthcare
       facilities, and efforts to control the outbreak. This mission
       will provide information to the international community to aid
       in understanding the situation and its impact and enable sharing
       of experience and successful measures.
       The Committee wished to re-emphasize the importance of studying
       the possible source, to rule out hidden transmission and to
       inform risk management measures
       The Committee also emphasized the need for enhanced surveillance
       in regions outside Hubei, including pathogen genomic sequencing,
       to understand whether local cycles of transmission are
       occurring.
       WHO should continue to use its networks of technical experts to
       assess how best this outbreak can be contained globally.
       WHO should provide intensified support for preparation and
       response, especially in vulnerable countries and regions.
       Measures to ensure rapid development and access to potential
       vaccines, diagnostics, antiviral medicines and other
       therapeutics for low- and middle-income countries should be
       developed.
       WHO should continue to provide all necessary technical and
       operational support to respond to this outbreak, including with
       its extensive networks of partners and collaborating
       institutions, to implement a comprehensive risk communication
       strategy, and to allow for the advancement of research and
       scientific developments in relation to this novel coronavirus.
       WHO should continue to explore the advisability of creating an
       intermediate level of alert between the binary possibilities of
       PHEIC or no PHEIC, in a way that does not require reopening
       negotiations on the text of the IHR (2005).
       WHO should timely review the situation with transparency and
       update its evidence-based recommendations.
       The Committee does not recommend any travel or trade restriction
       based on the current information available.
       The Director-General declared that the outbreak of 2019-nCoV
       constitutes a PHEIC and accepted the Committee’s advice and
       issued this advice as Temporary Recommendations under the IHR.
       To the People’s Republic of China
       Continue to:
       • Implement a comprehensive risk communication strategy to
       regularly inform the population on the evolution of the
       outbreak, the prevention and protection measures for the
       population, and the response measures taken for its containment.
       • Enhance public health measures for containment of the current
       outbreak.
       • Ensure the resilience of the health system and protect the
       health workforce.
       • Enhance surveillance and active case finding across China.
       • Collaborate with WHO and partners to conduct investigations to
       understand the epidemiology and the evolution of this outbreak
       and measures to contain it.
       • Share relevant data on human cases.
       • Continue to identify the zoonotic source of the outbreak, and
       particularly the potential for circulation with WHO as soon as
       it becomes available.
       • Conduct exit screening at international airports and ports,
       with the aim of early detection of symptomatic travelers for
       further evaluation and treatment, while minimizing interference
       with international traffic.
       To all countries
       It is expected that further international exportation of cases
       may appear in any country. Thus, all countries should be
       prepared for containment, including active surveillance, early
       detection, isolation and case management, contact tracing and
       prevention of onward spread of 2019-nCoVinfection, and to share
       full data with WHO. Technical advice is available on the WHO
       website.
  HTML https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance
       Countries are reminded that they are legally required to share
       information with WHO under the IHR.
       Any detection of 2019-nCoV in an animal (including information
       about the species, diagnostic tests, and relevant
       epidemiological information) should be reported to the World
       Organization for Animal Health (OIE) as an emerging disease.
       Countries should place particular emphasis on reducing human
       infection, prevention of secondary transmission and
       international spread, and contributing to the international
       response though multi-sectoral communication and collaboration
       and active participation in increasing knowledge on the virus
       and the disease, as well as advancing research.
       The Committee does not recommend any travel or trade restriction
       based on the current information available.
       Countries must inform WHO about any travel measures taken, as
       required by the IHR. Countries are cautioned against actions
       that promote stigma or discrimination, in line with the
       principles of Article 3 of the IHR.
       The Committee asked the Director-General to provide further
       advice on these matters and, if necessary, to make new
       case-by-case recommendations, in view of this rapidly evolving
       situation.
       To the global community
       As this is a new coronavirus, and it has been previously shown
       that similar coronaviruses required substantial efforts to
       enable regular information sharing and research, the global
       community should continue to demonstrate solidarity and
       cooperation, in compliance with Article 44 of the IHR (2005), in
       supporting each other on the identification of the source of
       this new virus, its full potential for human-to-human
       transmission, preparedness for potential importation of cases,
       and research for developing necessary treatment.
       Provide support to low- and middle-income countries to enable
       their response to this event, as well as to facilitate access to
       diagnostics, potential vaccines and therapeutics.
       Under Article 43 of the IHR, States Parties implementing
       additional health measures that significantly interfere with
       international traffic (refusal of entry or departure of
       international travellers, baggage, cargo, containers,
       conveyances, goods, and the like, or their delay, for more than
       24 hours) are obliged to send to WHO the public health rationale
       and justification within 48 hours of their implementation. WHO
       will review the justification and may request countries to
       reconsider their measures. WHO is required to share with other
       States Parties the information about measures and the
       justification received.
       The Emergency Committee will be reconvened within three months
       or earlier, at the discretion of the Director-General.
       The Director-General thanked the Committee for its work.
       *****************************************************